An investigation into the use of anafranil in phobic and obsessional disorders
- PMID: 1154017
- DOI: 10.1177/00369330750200S113
An investigation into the use of anafranil in phobic and obsessional disorders
Abstract
A multicentre clinical trial of clomipramine in the treatment of obsessional and phobic disorders in general practice is described. All phobias showed an improvement in situational anxiety, interference and autonomic side effects. With the exception of two cases of animal phobia there was also improvement in general anxiety and avoidance. Obsessional cases showed an overall improvement in all symptom areas.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
